| Date | Title | Description |
| 24.08.2026 | Twin1 AI Secures $20M for Enterprise Digital Twins | Twin1 AI launches from stealth. It secures $20 million in seed funding. This capital fuels AI-powered digital twins for professionals. The technology captures individual knowledge, judgment, and work context. It operates across vital enterp... |
| 24.08.2026 | Aramco Ventures backs Twin1 AI in $20 M Seed funding round | US-based enterprise AI startup Twin1 AI has raised $20 million in a Seed round co-led by Bessemer Venture Partners, Tribeca Venture Partners and Saudi-based Aramco Ventures as the company emerges from stealth to scale its AI-powered digital... |
| 21.08.2026 | Twin1 AI Raises $20 Million Seed As Digital Twin Platform Automates 30% To 50% Of Knowledge Worker Communications | Twin1 AI has emerged from stealth with a $20 million seed financing to scale an enterprise platform that creates AI-powered digital twins for professional knowledge workers. Bessemer Venture Partners, Tribeca Venture Partners and Aramco Ven... |
| 21.08.2026 | Twin1 AI Emerges With $20M Seed Round |
SAN MATEO, CA, Twin1 AI has announced its launch from stealth alongside a $20 million seed funding round.
>> Click here for more funding data on Twin1 AI
>> To export Twin1 AI funding data to PDF and Excel, click here
Twin1 AI,... |
| 20.08.2026 | Twin1 AI emerges from stealth with $20M in funding to give every professional an AI-powered digital twin | Twin1 AI is betting that the next big enterprise AI interface won’t be another chatbot. It will be a digital version of you.
The San Mateo, California-based startup emerged from stealth Thursday with $20 million in seed funding to build AI-... |
| 20.08.2026 | Twin1 AI Raises $20M in Seed Funding | Twin1 AI, a San Mateo, CA-based provider of an AI-powered digital twin platform for knowledge workers, raised $20M in Seed funding.
The round was co-led by Bessemer Venture Partners, Tribeca Venture Partners, and Aramco Ventures, with parti... |
| 20.08.2026 | AI startup raises $20m to build ‘digital twins’ of office workers | An AI startup that creates digital replicas of employees has raised $20m (£15m) as investors bet that technology used to model factories and machinery can be applied to office workers.
Twin1 AI emerged from “stealth” on Thursday after secur... |
| 17.08.2026 | Silicon Data Secures $30.5 Million, Transforms AI Compute Economy | Silicon Data, an NYC-based market intelligence leader for the AI compute economy, closed a $30.5 million Series A. This brings total funding to $35.2 million. Valor Atreides AI Fund spearheaded the investment. The capital fuels strategic gr... |
| 12.08.2026 | Silicon Data Raises $30.5 Million Series A |
NEW YORK, NY, Silicon Data, the independent benchmark and verification layer for the compute economy, announced a $30.5 million initial closing of its Series A, led by the Valor Atreides AI Fund.
>> Click here for more funding data o... |
| 12.08.2026 | Silicon Data Raises $30.5M in Series A Funding | Silicon Data, a NYC-based provider of a market intelligence platform for the AI compute economy, raised $30.5M in the initial closing of its Series A funding.
The round was led by Valor Atreides AI Fund, with participation from CME Group, D... |
| 11.08.2026 | Fazeshift Receives Investment From Amex Ventures | Fazeshift, a San Francisco, CA-based provider of an AI-native platform deploying autonomous agents to execute end-to-end accounts receivable workflows, received an investment from Amex Ventures.
The amount of the deal was not disclosed.
The... |
| 27.07.2026 | Venture capital & startup funding roundup, July 27, 2026: B Capital, Index Ventures, Paradigm, Point72 Ventures, Ribbit Capital & more | Today’s funding activity tells a familiar story: investors are writing fewer big checks, but they’re writing them with greater conviction. Rather than spreading capital widely, venture firms concentrated their bets on companies building tec... |
| 27.07.2026 | Flourish Health Raises $26M to Expand In-Home High-Acuity Pediatric Mental Health | What You Should Know
High-acuity pediatric mental health provider Flourish Health announced a $26M Series A funding round led by B Capital, F-Prime, and Cherryrock Capital, bringing total capital raised to $46M.
Health plan studies show Flo... |
| 08.07.2026 | Venice AI Achieves Unicorn Status with $65 Million Series A for Private Intelligence | Venice AI secured $65 million in Series A funding. This pushed its valuation to $1 billion. The company achieved unicorn status. It champions private, uncensored AI. Venice offers 200+ models. It guarantees user data sovereignty. Conversati... |
| 06.07.2026 | Venice Raises $65 Million Series A At $1 Billion Valuation | Venice announced that it has raised $65 million in Series A funding at a $1 billion valuation. The round was led by Dragonfly, with participation from Coinbase Ventures, F-Prime, North Island Ventures, and other investors.
The financing rep... |
| 01.07.2026 | Venice raises $65M at $1B valuation for private, uncensored AI | Privacy-focused artificial intelligence company Venice.ai Inc. today revealed that it has raised $65 million in new funding that values the startup at $1 billion.
Venice pitches itself as a private and unrestricted alternative to mainstream... |
| 30.06.2026 | Pie Raises $23.7 Million To Bring AI-Powered Growth To Main Street Businesses | Pie announced that it has raised $19.5 million in Series A funding led by Lightspeed Venture Partners. The round brings Pie’s total funding to $23.7 million. The financing included participation from Capital One Ventures, Max Levchin’s SciF... |
| 30.06.2026 | Pie launches with $19.5M to bring AI marketing to small businesses | Pie Tech Inc., a startup using artificial intelligence to provide growth tools for small businesses, today officially launched with an announcement that it has raised $19.5 million in new funding to expand its platform and team.
The company... |
| 30.06.2026 | Pie Raises $19.5M in Series A Funding | Syed Ali (left), co-founder and CEO of Pie, and Akhil Mantripragada (right), co-founder and CTO of Pie
Pie, a NYC-based provider of an AI-powered growth platform for small businesses, raised $19.5m in Series A funding.
The round, which brou... |
| 23.06.2026 | BoolSi Secures $6M to Accelerate Custom Chip Development for Software Developers | BoolSi Inc. just secured $6M in seed funding. The Boston-based startup developed a groundbreaking compiler. It converts ordinary software code into custom hardware. This innovation democratizes chip design. It eliminates years of specialize... |
| 23.06.2026 | BoolSi Raises $6 Million Seed To Build Compiler For Custom FPGA Accelerators | BoolSi announced that it has raised $6 million in seed funding to build a compiler that enables software engineers to create custom hardware accelerators without needing chip design expertise.
The round was led by Fine Structure Ventures, a... |
| 19.06.2026 | BoolSi Raises $6M to Let Software Engineers Build Custom Chips Using Backpropagation | By Richard L. Wells
Published: Jun 19 2026, 10:03 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 18.06.2026 | BoolSi raises $6M to compile ordinary code into custom chips | Chip-design startup BoolSi Inc. today announced it has raised $6 million in seed funding to build a compiler that turns ordinary software into custom hardware, doing away with the years of digital-logic training that chip design has always ... |
| 08.06.2026 | Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, others | Synopsis
The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patientâs own immune cells are taken out, trained in a lab to fight cancer, and then put back into the body. The treatment has been seen as a maj... |
| 08.06.2026 | Immuneel Therapeutics Raises ₹100 Cr To Take Its Gene Therapy For Blood Cancer Global | SUMMARY
Bengaluru-based Immuneel Therapeutics has raised ₹100 Cr Series B fundraise from Singularity AMC, Rainmatter by Zerodha
The round also saw participation from existing investors, including founder Kiran Mazumdar-Shaw, Eight Roads Ven... |
| 08.06.2026 | Eight Roads-backed Immuneel bags Series B funding for advanced cancer care | (Representative image)
Immuneel Therapeutics, a cell and gene therapy startup co-founded by Biocon founder Kiran Mazumdar-Shaw, secured Series B funding to scale up its manufacturing capacity for cell therapy targeting a specific group of b... |
| 01.06.2026 | Countable Labs Secures $26M to Advance Precision Genomics with Countable PCR | Countable Labs just raised $26 million. This oversubscribed funding round accelerates commercialization of its Countable PCR technology. The platform offers single-molecule quantification, outperforming digital PCR in sensitivity and precis... |
| 28.05.2026 | Countable Labs Raises $26 Million To Accelerate Countable PCR Commercialization | Countable Labs announced it has raised $26 million in an oversubscribed financing round to accelerate clinical product development and global commercialization of its Countable PCR technology.
The financing round was led by ARCH Venture Par... |
| 28.05.2026 | Countable Labs Raises $26M in Funding | Countable Labs, the Palo Alto, Ca-based developer of Countable PCR, a single-molecule PCR technology, raised $26M in funding.
The round was led by ARCH Venture Partners with participation from F-Prime Capital and Primer Ventures.
The compan... |
| 13.05.2026 | Fazeshift Secures $17M to Revolutionize Finance with AI-Native Automation | Fazeshift recently closed a significant $17 million Series A funding round. F-Prime spearheaded the investment. This brings the company's total capital to $22 million. Fazeshift delivers groundbreaking AI-native software. It deploys autonom... |
| 09.05.2026 | Fazeshift Raises $17 Million Series A To Automate Accounts Receivable Workflows With AI Agents | Fazeshift announced that it has raised $17 million in Series A funding led by F-Prime, bringing the company’s total funding to $22 million. Investors in the round also included Gradient, Y Combinator, Wayfinder, Pioneer Fund, Ritual Capital... |
| 08.05.2026 | Fazeshift Raises $17M in Series A Funding | Fazeshift, a San Francisco, CA-based provider of an AI-native platform deploying autonomous agents to execute end-to-end accounts receivable workflows, raised $17M in Series A funding.
The round was led by F-Prime, with participation from G... |
| 27.04.2026 | Almanac Health Boosts Clinical AI Trust with $10M Funding | Almanac Health secured $10 million in a seed round, bringing total funding to nearly $12 million. The company introduces research-validated clinical AI. It aims to empower physicians with specialist-grade knowledge. The platform integrates ... |
| 23.04.2026 | Almanac Health Launches with $10M to Scale Research-Validated Clinical AI for Point-of-Care Support | What You Should Know
Almanac Health has raised $10M in a seed round led by F-Prime, with participation from General Catalyst and Lightspeed Venture Partners, bringing total funding to nearly $12M.
The platform was founded by Cyril Zakka, MD... |
| 17.03.2026 | Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306 | AP306 is a first-in-class pan-phosphate transporter inhibitor in development for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) receiving dialysis
Alebund grants exclusive rights to develop, manufacture, an... |
| 17.03.2026 | R1 Therapeutics: $77.5 Million Raised To Advance Kidney Disease Treatment | R1 Therapeutics, a clinical-stage biopharmaceutical company focused on kidney disease, has launched with an oversubscribed $77.5 million Series A financing to advance a first-in-class treatment for hyperphosphatemia in patients with chronic... |
| 17.03.2026 | R1 Therapeutics Raises $77.5M in Series A Funding | R1 Therapeutics, a Redwood City, CA-based clinical-stage biopharmaceutical company, raised $77.5M in Series A funding.
The round was co-led by Abingworth, F-Prime, and DaVita Venture Group, with participation from Curie.Bio, SymBiosis, and ... |
| 03.03.2026 | STS Digital: $30 Million Raised By Digital Asset Derivatives Trading Firm To Scale Crypto Options Platform | STS Digital, a regulated principal trading firm specializing in digital asset derivatives and institutional market access, announced it has closed a $30 million strategic funding round to accelerate the growth of its crypto options trading ... |
| 02.03.2026 | STS Digital raises USD 30 million to scale its crypto options trading platform |
The strategic round comes as crypto derivatives, particularly options, have increasingly been used for hedging, yield strategies, and volatility exposure, rather than purely directional trading, bridging the gap between digital assets and ... |
| 02.03.2026 | Jump raises $80 million | Jump - Advisor AI Jump - Advisor AI
Founded: 2023
Headquarters: Salt Lake City, Utah, United States
Total Funding: $109.17M
See full company profile "> , an AI productivity platform for financial advisors, raised $80 million in Seri... |
| 02.03.2026 | Ease Health Emerges from Stealth with $41M for AI-Native Behavioral Health OS | - |
| 28.02.2026 | STS Digital Secures $30M To Expand Institutional Crypto Options Platform | STS Digital closed a $30 million strategic funding round. This capital infusion fuels the rapid expansion of its institutional-grade crypto options and spot trading platform. The investment strengthens the firm's market-making capabilities ... |
| 27.02.2026 | STS Digital Raises $30M in Funding | STS Digital, a Zug, Switzerland-based principal trading company specialised in digital-asset derivatives, raised $30M in funding.
The round was led by CMT Digital, with participation from Payward, Strobe Ventures, Arrington Capital, F-Prime... |
| 26.02.2026 | STS Digital: $30 Million Strategic Round Closed For Crypto Options Trading Platform Expansion | STS Digital announced it has closed a $30 million strategic funding round led by CMT Digital, with participation from Payward, Strobe Ventures, Arrington Capital, F-Prime, and BitRock Capital, to accelerate the growth of its crypto options ... |
| 23.02.2026 | Jump Secures $80 Million, Accelerating AI Transformation in Financial Advisory | Jump, a pioneering AI platform for financial advisors, has successfully closed an $80 million Series B funding round, elevating its total capital to $105 million. This substantial investment will accelerate the development of its AI-native ... |
| 22.02.2026 | Jump: $80 Million Series B Secured For Expanding Advisor Intelligence Engine | Jump, an AI platform built for financial advisors and other financial services professionals, announced it has closed an $80 million Series B funding round led by Insight Partners. The round included participation from new investors F-Prime... |
| 19.02.2026 | Jump Raises $80M in Series B Funding | Jump, a Salt Lake City, UT-based provider of artificial intelligence (AI) solutions for financial advisors and other financial services providers, raised $80M in Series B funding.
The round was led by Insight Partners with participation fro... |
| 02.02.2026 | Tenpoint Therapeutics Secures $235M, Prepares YUVEZZI Launch for Presbyopia | Tenpoint Therapeutics secured $235 million in new capital. This robust funding fuels the impending launch of YUVEZZI. YUVEZZI is an FDA-approved, first-of-its-kind dual-agent eye drop. It targets presbyopia, a widespread aging vision condit... |
| 30.01.2026 | Tenpoint Therapeutics: $235 Million Raised To Launch YUVEZZI Presbyopia Eye Drop | Tenpoint Therapeutics has secured $235 million in new funding to support the planned commercialization of its presbyopia treatment, YUVEZZI. The company said the capital combines an $85 million Series B preferred stock financing and a $150 ... |
| 29.01.2026 | Tenpoint Therapeutics Raises $235M Through Series B and Credit Facility | Tenpoint Therapeutics, Ltd., a London, UK and Seattle, WA-based provider of vision rejuvenation treatments for the aging eye, raised $235m through a Series B stock financing and a credit facility.
The company raised $85m in Series B financi... |
| 29.01.2026 | Tenpoint Therapeutics: $235 Million Raised To Launch Dual Agent Presbyopia Eye Drop YUVEZZI | Tenpoint Therapeutics said it has secured $235 million in new capital, combining an $85 million Series B preferred stock financing with a $150 million senior secured term loan facility, as the company prepares to commercialize its newly app... |
| 26.01.2026 | alfred Raises $15M in Series A Funding | CEO and co-founder Diego Yánez and co-founder Matías Plano
alfred, a Mexico City, Mexico based-provider of cross-border payment infrastructure, raised $15m in Series A funding.
The round was led by F-Prime Capital, with participation from B... |
| 24.01.2026 | Digital Health Leader Oviva Secures $200M for Chronic Care Expansion | Oviva, a European digital health pioneer, closed a $200 million Series D funding round. Kinnevik led the investment, becoming its largest shareholder. The company offers AI-powered virtual care for chronic conditions like obesity. Its evide... |
| 23.01.2026 | ETtech Deals Digest: Startups raise $400 million this week, up 7x on-year | Synopsis
The number of deals during the week remained nearly unchanged at 41, compared to 42 in the corresponding week last year.
Listen to this article in summarized format
Listen
ETtech
Startups raised around $400.4 million between Januar... |
| 22.01.2026 | Unbox Robotics Fuels Global Logistics Revolution with $28M Series B | Unbox Robotics, a pioneer in supply chain automation, has successfully closed a $28 million Series B funding round. ICICI Venture and Redstart Labs led the investment. The Pune-based company designs modular robotic systems. These systems en... |
| 22.01.2026 | HealthTech Oviva erhält 200 Millionen – Decathlon übernimmt Rebike – Kolsquare kauft Storyclash | Im #DealMonitor für den 22. Januar werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-A... |
| 20.01.2026 | ICICI Venture, Redstart Labs co-lead Unbox Robotics’ Series B round | Unbox Robotics' leadership team
Pune-based supply chain robotics technology company Unbox Robotics has raised $28 million (around Rs 255 crore) in its Series B funding round led by ICICI Venture, a wholly owned subsidiary of ICICI Bank focu... |
| 20.01.2026 | Warehouse automation startup Unbox Robotics raises $28 million led by ICICI Venture | Synopsis
Unbox Robotics has raised $28 million in a round led by ICICI Venture, with participation from RedStart Labs, a subsidiary of InfoEdge, F-Prime, 3one4 Capital, Navam Capital, Force Ventures and existing investors, ET has learnt. Th... |
| 20.01.2026 | Unbox Robotics: $28 Million Series B Closed For Supply Chain Robotics | Unbox Robotics has raised $28 million (INR 243 crore) in a Series B funding round led by ICICI Venture and Redstart Labs (Infoedge), with co-investment from F-Prime, 3one4 Capital, Navam Capital, Force Ventures, and other existing backers. ... |
| 20.01.2026 | Unbox Robotics raises $28M in Series B round led by ICICI Venture | Unbox Robotics, a supply chain robotics technology company, has raised $28 million (Rs 243 crore) in Series B funding, led by ICICI Venture and Redstart Labs (Infoedge), with co-investment from F-Prime, 3one4 Capital, Navam Capital, Force V... |
| 17.01.2026 | Digital Asset Firm Meld Closes $7M Round | This week, Meld announced the close of a $7 million strategic funding round led by Lightspeed Faction, with participation from F-Prime, Yolo Investments, and Scytale Digital. This financing advances Meld’s mission to enable stablecoin-drive... |
| 22.12.2025 | Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn | Plasmagen Biosciences CEO Vivek Kamath
PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures in its captable, has raised capital from a biopharma company and family offices to scale up its op... |
| 22.12.2025 | Eight Roads-backed PlasmaGen Biosciences raises Rs 150 crore at Rs 1,500 crore valuation | Synopsis
PlasmaGen Biosciences has secured Rs 150 crore in a funding round led by ViNS Bioproducts, valuing the company at over Rs 1,500 crore. This capital will fuel international expansion, product portfolio growth, and manufacturing enha... |
| 19.11.2025 | WellBeam Raises $10M Series A to Break EMR Silos Between Acute and Post-Acute Care | What You Should Know:
– WellBeam, a healthcare technology company, announced that it has successfully raised $10M in Series A funding led by Wittington Ventures and included participation from F-Prime, Advocate Health, and Oncology Ventures... |
| 18.11.2025 | T-Therapeutics Secures $91 Million to Advance Bispecific Therapies | T-Therapeutics boosts Series A to $91M. New funds will push cancer, autoimmune bispecifics to trials. OpTiMus platform aims to unlock undruggable targets. Investors show strong confidence.
**T-Therapeutics Secures $91 Million to Advance Bis... |
| 14.11.2025 | T-Therapeutics: Series A Extended To $91 Million As It Advances First-In-Class Bispecifics Toward The Clinic | T-Therapeutics has expanded its Series A financing to a total of $91 million after securing an additional $32 million from new and existing investors. The Cambridge-based biotechnology company, which develops next-generation T cell receptor... |
| 13.11.2025 | Cambridge startup T-Therapeutics secures €27.5 million to improve how the immune system targets disease | T-Therapeutics, a British BioTech company developing next-generation T cell receptor (TCR) therapeutics for cancer and autoimmune disease, today announced the successful expansion of its Series A financing, raising a further €27.5 million (... |
| 11.11.2025 | iRiva Medical Closes Initial Financing Round | iRiva Medical, Inc., a Minneapolis, MN-based development stage medical device company, and NuXcel spinoff, closed its initial financing round of undisclosed amount.
The round was led led by F-Prime, with participation from Hatteras Venture ... |
| 30.10.2025 | Hercle: $60 Million Raised For Scaling Institutional Infrastructure For Global Money Movement | Hercle, an institutional infrastructure company bridging stablecoins, digital assets, and cross-border settlement, announced $60 million in new financing. The raise includes a $10 million equity round led by F-Prime with participation from ... |
| 22.10.2025 | Украинский стартап Limitless получил $10 млн от международных инвесторов | Раунд возглавил американский венчурный фонд 1confirmation. Среди инвесторов проекта также — израильский фонд Collider, американские F-Prime Capital, Coinbase Ventures, Arrington Capital, китайский Node Capital, а также украинские партнеры F... |
| 20.10.2025 | Limitless Prediction Market Closes $10M Seed Round Ahead of LMTS Token Launch | Share
Share
Share
Share
Email
Limitless Exchange, the fastest-growing prediction market platform, has announced the close of a $10M seed round, led by 1confirmation with participation from Collider, F-Prime, DCG, Coinbase Ventures, Node Cap... |
| 18.10.2025 | Leyden Labs Secures €30M for Groundbreaking Respiratory Nasal Spray | Leyden Laboratories, a Dutch biotechnology pioneer, recently secured a significant €30 million in equity funding. The European Innovation Council (EIC) Fund and Invest-NL spearheaded this investment. This crucial capital injection will prop... |
| 17.10.2025 | Leyden Labs: €30 Million Secured From EIC And Invest-NL | Dutch biotechnology company Leyden Laboratories B.V. has secured €30 million in new equity financing from the European Innovation Council (EIC) Fund and Invest-NL. The investment will accelerate the clinical development of the company’s pan... |
| 17.10.2025 | Affinia Therapeutics: $40 Million Series C Raised For Advancing Gene Therapies For Cardiovascular And Neurological Diseases | Affinia Therapeutics, a biotechnology company pioneering engineered adeno-associated virus (AAV) gene therapies for severe cardiovascular and neurological conditions, has announced the closing of a $40 million Series C financing round. The ... |
| 16.10.2025 | ABK Biomedical Secures $35M: Advancing Imageable Embolotherapy for Cancer | ABK Biomedical secured $35M Series D funding, led by J.P. Morgan Life Sciences. This investment fuels Eye90 microspheres' clinical operations, commercialization, and manufacturing expansion. Eye90, an FDA Breakthrough Device, enhances Y90 r... |
| 15.10.2025 | ABK Biomedical: $35 Million Series D Secured For Advancing Clinical Development Of Eye90 Microspheres | ABK Biomedical, a medical device company specializing in advanced imageable embolic technologies, has raised an oversubscribed $35 million in its Series D funding round. The investment was led by new investor J.P. Morgan Life Sciences Priva... |
| 14.10.2025 | ABK Biomedical Raises US$35M in Series D Funding | ABK Biomedical, Inc., an Halifax, NS, Canada-based innovative medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, raised US$35m in Series D financing.
The round... |
| 09.10.2025 | AviadoBio and UgeneX Therapeutics Announce Exclusive Option-License Agreement to Develop Next Generation Optogenetics Gene Therapy to Restore Vision in Patients with Retinal Disease | LONDON, and SHANGHAI – October 9, 2025 – AviadoBio Ltd. (“AviadoBio”), and UgeneX Therapeutics, today announced an exclusive option and license agreement for the development and commercialization of UGX-202, an investigational, AAV-based ge... |
| 08.10.2025 | Affinia Therapeutics Raises $40M in Series C Financing | Affinia Therapeutics, a Waltham, MA-based gene therapy company with a pipeline of first-in-class and/or adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases, raised $40M in Series C financing.... |
| 26.09.2025 | Ensoma Secures $53M to Accelerate In Vivo Stem Cell Gene Therapies | Ensoma has secured $53 million in a pivotal funding round. This capital infusion accelerates its groundbreaking work in one-time, in vivo stem cell therapies. A primary goal involves progressing the Phase 1/2 clinical trial for EN-374, spec... |
| 26.09.2025 | AmplifyMD Secures $20M to Scale AI-Driven Virtual Specialty Care | What You Should Know:
– AmplifyMD, an integrated virtual care solution provider secures $20M in Series B funding led by Forerunner Ventures with participation from F-Prime, Greylock, Tau Ventures, and strategic partner Memorial Hermann Heal... |
| 24.09.2025 | AmplifyMD Raises $20M in Series B Funding | AmplifyMD, a Los Gatos, CA-based provider of a integrated virtual care solution, raised $20M in Series B funding.
The round was led by Forerunner Ventures with participation from F-Prime, Greylock, Tau Ventures, and strategic partner Memori... |
| 23.09.2025 | Ensoma Raises $53M in Funding | Ensoma, a Boston, MA-based in vivo hematopoietic stem cell (HSC) engineering company, raised $53M in funding.
Backers included Gilead (Nasdaq: GILD), which has also appointed an executive to the Ensoma board of directors as part of its inve... |
| 23.09.2025 | Ensoma: $53 Million Secured To Advance Stem Cell Therapies And Global Clinical Impact | Ensoma, a biotechnology company focused on transforming medicine through one-time, in vivo stem cell therapies, has announced the closing of a $53 million funding round. This investment comes from a group of leading investors who have previ... |
| 16.09.2025 | Kintsu Launches sHYPE on Hyperliquid | Share
Share
Share
Share
Email
Kintsu, a liquid staking protocol supported by investors including Castle Island Ventures, Brevan Howard Digital, CMT Digital, Spartan, Arche Capital, and F-Prime, has announced its expansion to Hyperliquid wit... |
| 11.09.2025 | Spinwheel: Strategic Investment Secured For Advancing Future Of Consumer Credit Ecosystem | Spinwheel, the agentic AI-powered credit data and payments platform, announced a strategic investment from Citi Ventures. The funding will support Spinwheel’s continued go-to-market growth, expand its agentic AI platform, and build out its ... |
| 08.09.2025 | Dispatch: $18 Million Series A Raised For AI-Driven Data Infrastructure For Financial Advisors | Wealthtech leader Dispatch announced the closing of its $18 million Series A funding round, bringing its total capital raised to $30 million. The round was led by Brewer Lane Ventures and included participation from New York Life Ventures, ... |
| 07.09.2025 | Charm Therapeutics Secures $80M for AI-Driven Cancer Battle | Charm Therapeutics, a London-based biotech firm, clinched $80M in Series B funding. This investment fuels its AI-driven drug discovery platform. The company targets precision oncology, focusing on acute myeloid leukemia (AML). Its lead meni... |
| 07.09.2025 | Spinwheel Secures Citi Ventures Investment For Agentic AI Credit Data and Payments Platform | Spinwheel, an agentic AI-powered credit data and payments platform, has received a strategic investment from Citi Ventures. The funding will support Spinwheel’s continued go-to-market growth, expand its agentic AI platform, and build out it... |
| 05.09.2025 | Dispatch Raises $18M in Series A Funding | Dispatch, a Miami, FL-based wealthtech solution provider enabling effortless client data management, raised $18M Series A funding.
The round was led by Brewer Lane Ventures, with participation from New York Life Ventures, MassMutual Venture... |
| 02.09.2025 | Charm Therapeutics Raises $80M in Series B Financing | Charm Therapeutics, a London, UK-based biotechnology company which specializes in precision oncology treatments, raised $80M in Series B funding.
The round was led by New Enterprise Associates (NEA) and SR One, with participation from exist... |
| 02.09.2025 | London’s CHARM Therapeutics raises €68.5 million financing to tackle treatment-resistant cancers | British BioTech startup CHARM Therapeutics, announces closing of an oversubscribed Series B funding round, raising €68.5 million to advance its next generation menin inhibitor into clinical development.
The funding round was co-led by New E... |
| 20.08.2025 | Robotics startup FieldAI raises $314 million in new funding, sources say | Synopsis
FieldAI said it has raised $405 million over two funding rounds to scale its artificial intelligence platform but did not break out its latest financing. It added that backers include Khosla Ventures, Nvidia's NVentures, Bezos Expe... |
| 09.08.2025 | Apreo Health Secures $130M to Revolutionize Emphysema Care | Apreo Health secured $130 million in Series B funding. This major investment propels its BREATHE Airway Scaffold, an innovative medical device for severe emphysema. The scaffold addresses lung hyperinflation, aiming to redefine treatment fo... |
| 08.08.2025 | Apreo Health: $130 Million Series B Raised For Developing Treatments For Severe Emphysema | Apreo Health, a clinical-stage medical device company focused on innovative treatments for severe emphysema, has announced the successful completion of an oversubscribed $130 million Series B financing round. This funding was jointly led by... |
| 07.08.2025 | Artbio Secures $132M to Accelerate Precision Cancer Therapies | Artbio, a pioneering radiopharmaceutical firm, locked in $132 million Series B funding. This investment drives AB001, its innovative alpha radioligand therapy for metastatic castration-resistant prostate cancer, toward Phase II clinical tri... |
| 07.08.2025 | ARTBIO: $132 Million Series B Raised For New Class Of Alpha Radioligand Therapies | ARTBIO, a clinical-stage radiopharmaceutical company, is focused on developing alpha radioligand therapies (ARTs) for various types of cancer. The company has secured $132 million in Series B financing, co-led by new investors Sofinnova Inv... |
| 07.08.2025 | Apreo Health Closes $130M in Series B Financing | Apreo Health, a Menlo Park, CA-based clinical-stage medical device company developing a novel treatment for severe emphysema, raised $130M in Series B funding.
The round was led by Bain Capital Life Sciences and Norwest, with participation ... |
| 29.07.2025 | ARTBIO Raises $132M in Series B Financing | ARTBIO, a Cambridge, MA-based clinical-stage radiopharmaceutical company, raised $132M in Series B funding.
The round was led by Sofinnova Investments and B Capital, along with an existing investor and participation from F-Prime, Omega Fund... |
| 24.07.2025 | MoEngage is the only vendor recognized as a Customers' Choice in the 2025 Gartner Peer Insights™ Voice of the Customer for Email Marketing | SAN FRANCISCO, July 24, 2025 /PRNewswire/ -- MoEngage, the world's leading customer engagement platform, is proud to announce its recognition as the only vendor named a Customers' Choice in the 2025 Gartner Peer Insights™ Voice of the Custo... |